loading page

Polycythemia vera in a 2-year-old child with a JAK2 exon 12 deletion
  • +2
  • Sarah Mc Dermott,
  • Nicole Kucine,
  • Midhat Farooqi,
  • Weijie Li ,
  • Michael Silvey
Sarah Mc Dermott
Children's Mercy Hospital
Author Profile
Nicole Kucine
Weill Cornell Medical College
Author Profile
Midhat Farooqi
Children's Mercy Hospital
Author Profile
Weijie Li
Children's Mercy Hospital
Author Profile
Michael Silvey
Children's Mercy Hospital
Author Profile

Abstract

Polycythemia vera (PV) is a myeloproliferative neoplasm primarily characterized by erythrocytosis. PV incidence is exceedingly rare in the pediatric and adolescent population. In adult patients, approximately 96% are found to have a somatic mutation in exon 14 (JAK2 V617F) and 3% display a mutation in exon 12. We present a case of a 2-year-old female with symptomatic PV secondary to a deletion in exon 12 of JAK2, initially treated with phlebotomy and switched to PEG-IFNα-2a therapy. This therapy has been effective over 15 months with resolution of symptoms, reduced phlebotomy requirements, and minimal side effects.